NCT02096315View on ClinicalTrials.gov

Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.

PHASE2TerminatedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

BronchiectasisLower Respiratory Infection

Interventions

DRUG

POL7080

Intravenous infusion

Trial Locations (4)

Unknown

Hospital Bellvitge, Barcelona

Hospital Clinic, Barcelona

Hospital La Fe, Valencia

Royal Infirmary, City of Edinburgh

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Polyphor Ltd.

INDUSTRY